交易 Quince Therapeuticks Inc - QNCX CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.0462 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Quince Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 1.0469 | -0.0600 | -5.42% | 1.1069 | 1.1069 | 1.0269 |
Mar 27, 2024 | 1.0869 | -0.0600 | -5.23% | 1.1469 | 1.1469 | 1.0369 |
Mar 26, 2024 | 1.0969 | -0.1000 | -8.35% | 1.1969 | 1.1969 | 1.0969 |
Mar 25, 2024 | 1.1769 | 0.0000 | 0.00% | 1.1769 | 1.1769 | 1.1569 |
Mar 22, 2024 | 1.1669 | 0.0000 | 0.00% | 1.1669 | 1.1769 | 1.1669 |
Mar 21, 2024 | 1.1569 | 0.0300 | 2.66% | 1.1269 | 1.1969 | 1.1269 |
Mar 20, 2024 | 1.1369 | -0.0400 | -3.40% | 1.1769 | 1.1969 | 1.1169 |
Mar 19, 2024 | 1.1869 | 0.0300 | 2.59% | 1.1569 | 1.1969 | 1.1569 |
Mar 18, 2024 | 1.1569 | 0.0000 | 0.00% | 1.1569 | 1.1669 | 1.1269 |
Mar 15, 2024 | 1.1369 | -0.0300 | -2.57% | 1.1669 | 1.1669 | 1.1169 |
Mar 14, 2024 | 1.1269 | -0.0100 | -0.88% | 1.1369 | 1.1369 | 1.1169 |
Mar 13, 2024 | 1.1469 | -0.0600 | -4.97% | 1.2069 | 1.2169 | 1.1269 |
Mar 12, 2024 | 1.1869 | 0.0200 | 1.71% | 1.1669 | 1.2069 | 1.1469 |
Mar 11, 2024 | 1.1569 | -0.0100 | -0.86% | 1.1669 | 1.1869 | 1.1569 |
Mar 8, 2024 | 1.1369 | -0.0500 | -4.21% | 1.1869 | 1.2069 | 1.1169 |
Mar 7, 2024 | 1.1269 | -0.0500 | -4.25% | 1.1769 | 1.1969 | 1.1169 |
Mar 6, 2024 | 1.1369 | -0.0400 | -3.40% | 1.1769 | 1.1769 | 1.1369 |
Mar 5, 2024 | 1.1569 | -0.0300 | -2.53% | 1.1869 | 1.1869 | 1.1469 |
Mar 4, 2024 | 1.1700 | -0.0800 | -6.40% | 1.2500 | 1.2750 | 1.1500 |
Mar 1, 2024 | 1.2800 | -0.0200 | -1.54% | 1.3000 | 1.3300 | 1.2486 |
Quince Therapeuticks Inc Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, April 1, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q4 2023 Quince Therapeutics Inc Earnings Release Q4 2023 Quince Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Monday, May 13, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q1 2024 Quince Therapeutics Inc Earnings Release Q1 2024 Quince Therapeutics Inc Earnings ReleaseForecast(預報) -返回 - |
Thursday, May 23, 2024 | ||
時間 (UTC) 18:00 | 國家 US
| 事件 Quince Therapeutics Inc Annual Shareholders Meeting Quince Therapeutics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 52.015 | 90.318 | 78.893 | 39.168 | 12.119 |
銷售/一般/行政費用,總計 | 26.012 | 29.523 | 17.586 | 8.954 | 2.034 |
研究與開發 | 25.178 | 60.795 | 61.307 | 30.214 | 10.085 |
營業收入 | -52.015 | -90.318 | -78.893 | -39.168 | -12.119 |
利息收入(費用),非經營淨值 | 1.068 | 0.62 | 2.044 | 2.188 | -0.357 |
稅前淨收入 | -51.944 | -89.945 | -76.849 | -36.98 | -12.476 |
稅後淨收入 | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
未計算非常項目前的淨收益 | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
非常規項目總計 | |||||
淨收入 | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
普通股股東可獲收益 (不含非經常性項目) | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
普通股股東可獲收益 (含非經常性項目) | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
攤薄淨收入 | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
攤薄後加權平均股 | 33.4965 | 29.7185 | 29.1762 | 19.0319 | 26.0133 |
扣除特別項目的每股攤薄盈利 | -1.54225 | -3.02657 | -2.63396 | -1.94305 | -0.4796 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -1.52624 | -3.02657 | -2.63396 | -1.94305 | -0.4796 |
其他,淨值 | -0.997 | -0.247 | |||
異常費用(收入) | 0.825 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 5.584 | 13.022 | 6.319 | 7.62 | 16.258 |
銷售/一般/行政費用,總計 | 4.231 | 3.826 | 3.551 | 4.344 | 9.059 |
研究與開發 | 1.353 | 3.23 | 2.768 | 2.451 | 7.199 |
營業收入 | -5.584 | -13.022 | -6.319 | -7.62 | -16.258 |
利息收入(費用),非經營淨值 | 0.805 | 0.7 | 0.536 | 0.315 | 0.145 |
稅前淨收入 | -4.886 | -12.502 | -5.534 | -7.921 | -16.848 |
稅後淨收入 | -4.886 | -12.254 | -5.534 | -7.921 | -16.564 |
未計算非常項目前的淨收益 | -4.886 | -12.254 | -5.534 | -7.921 | -16.564 |
淨收入 | -4.886 | -12.254 | -5.534 | -7.921 | -16.564 |
普通股股東可獲收益 (不含非經常性項目) | -4.886 | -12.254 | -5.534 | -7.921 | -16.564 |
普通股股東可獲收益 (含非經常性項目) | -4.886 | -12.254 | -5.534 | -7.921 | -16.564 |
攤薄淨收入 | -4.886 | -12.254 | -5.534 | -7.921 | -16.564 |
攤薄後加權平均股 | 35.9176 | 35.8552 | 35.7117 | 35.6128 | 32.467 |
扣除特別項目的每股攤薄盈利 | -0.13603 | -0.34176 | -0.15496 | -0.22242 | -0.51018 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.13603 | -0.23361 | -0.15496 | -0.19925 | -0.51018 |
其他,淨值 | -0.107 | -0.18 | 0.249 | -0.616 | -0.735 |
異常費用(收入) | 0 | 5.966 | 0 | 0.825 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 93.748 | 111.673 | 137.862 | 106.056 | 72.584 |
現金和短期投資 | 90.181 | 106.802 | 133.82 | 99.864 | 71.716 |
現金 | 3.986 | 40.27 | 35.69 | 4.074 | 11.259 |
現金等價物 | 10.988 | 15.954 | 16.151 | 46.155 | 11.815 |
短期投資 | 75.207 | 50.578 | 81.979 | 49.635 | 48.642 |
預付的費用 | 2.288 | 3.376 | 3.348 | 5.504 | 0.766 |
其他流動資産,總計 | 1.279 | 1.495 | 0.694 | 0.688 | 0.102 |
總資産 | 103.91 | 133.228 | 189.466 | 124.37 | 72.877 |
物業/廠房/設備,總計 - 淨額 | 0.684 | 1.428 | 1.101 | 1.334 | 0.283 |
物業/廠房/設備,總計 - 總額 | 0.869 | 2.387 | 1.716 | 1.617 | 0.378 |
累計折舊,總計 | -0.185 | -0.959 | -0.615 | -0.283 | -0.095 |
其他長期資産,總計 | 0 | 0.194 | 0.039 | 0.217 | 0.01 |
流動負債總額 | 3.069 | 14.222 | 16.996 | 8.892 | 1.457 |
應付賬款 | 0.57 | 4.911 | 3.555 | 3.075 | 0.495 |
預提費用 | 2.423 | 9.311 | 13.441 | 5.817 | 0.962 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 3.317 | 14.642 | 17.204 | 8.892 | 1.457 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
長期債務 | 0 | ||||
其他負債,總計 | 0 | 0.42 | 0.208 | 0 | |
股權 | 100.593 | 118.586 | 172.262 | 115.478 | 71.42 |
Redeemable Preferred Stock | 0 | 104.046 | |||
普通股 | 0.036 | 0.03 | 0.029 | 0.027 | 0.009 |
額外實收資本 | 389.105 | 355.234 | 318.574 | 185.196 | 0.239 |
留存收益(累計赤字) | -288.259 | -236.599 | -146.654 | -69.805 | -32.825 |
其他權益,總計 | -0.289 | -0.079 | 0.313 | 0.06 | -0.049 |
總負債和股東權益 | 103.91 | 133.228 | 189.466 | 124.37 | 72.877 |
已發行普通股總數 | 36.1303 | 30.0744 | 29.5432 | 26.8694 | 26.0133 |
長期投資 | 3.578 | 19.933 | 50.464 | 16.763 | |
無形資産,淨額 | 5.9 | ||||
長期債務的當前部分/資本租賃 | 0.076 | ||||
遞延所得稅 | 0.248 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 85.173 | 88.548 | 92.491 | 93.748 | 98.276 |
現金和短期投資 | 83.225 | 87.565 | 90.203 | 90.181 | 94.343 |
現金 | 0.809 | 2.026 | 4.449 | 3.986 | 10.233 |
現金等價物 | 12.285 | 9.329 | 15.863 | 10.988 | 15.012 |
短期投資 | 70.131 | 76.21 | 69.891 | 75.207 | 69.098 |
預付的費用 | 1.356 | 0.84 | 1.637 | 2.288 | 2.555 |
其他流動資産,總計 | 0.092 | 0.143 | 0.651 | 1.279 | 1.378 |
總資産 | 85.386 | 88.836 | 93.318 | 103.91 | 109.777 |
物業/廠房/設備,總計 - 淨額 | 0.053 | 0.116 | 0.177 | 0.684 | 0.583 |
物業/廠房/設備,總計 - 總額 | 0.066 | 0.128 | 0.189 | 0.869 | 0.742 |
累計折舊,總計 | -0.013 | -0.012 | -0.012 | -0.185 | -0.159 |
長期投資 | 0.078 | 0.078 | 0.545 | 3.578 | 5.001 |
其他長期資産,總計 | 0.082 | 0.094 | 0.105 | 0 | 0.017 |
流動負債總額 | 2.253 | 1.952 | 3.115 | 3.069 | 4.945 |
應付賬款 | 0.409 | 0.353 | 1.651 | 0.57 | 1.181 |
預提費用 | 1.844 | 1.599 | 1.464 | 2.423 | 3.689 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 2.253 | 1.952 | 3.115 | 3.317 | 5.246 |
長期債務總額 | 0 | 0 | 0 | 0 | 0.019 |
其他負債,總計 | 0 | 0.034 | |||
股權 | 83.133 | 86.884 | 90.203 | 100.593 | 104.531 |
普通股 | 0.036 | 0.036 | 0.036 | 0.036 | 0.036 |
額外實收資本 | 393.331 | 391.99 | 390.642 | 389.105 | 387.473 |
留存收益(累計赤字) | -310.75 | -305.399 | -300.513 | -288.259 | -282.725 |
其他權益,總計 | 0.516 | 0.257 | 0.038 | -0.289 | -0.253 |
總負債和股東權益 | 85.386 | 88.836 | 93.318 | 103.91 | 109.777 |
已發行普通股總數 | 36.3436 | 36.328 | 36.2784 | 36.1303 | 36.1303 |
商譽,淨額 | |||||
無形資産,淨額 | 0 | 0 | 0 | 5.9 | 5.9 |
長期債務的當前部分/資本租賃 | 0 | 0 | 0 | 0.076 | 0.075 |
資本租賃義務 | 0.019 | ||||
遞延所得稅 | 0 | 0 | 0 | 0.248 | 0.248 |
應收賬款總額,淨額 | 0.5 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -51.66 | -89.945 | -76.849 | -36.98 | -12.476 |
經營活動産生的現金 | -44.038 | -62.932 | -50.818 | -33.277 | -11.695 |
經營活動産生的現金 | 0.204 | 0.344 | 0.332 | 0.188 | 0.051 |
非現金物品 | 17.437 | 30.93 | 15.472 | 1.611 | 1.12 |
已付現金利息 | 0.001 | ||||
營運資金的變化 | -9.735 | -4.261 | 10.227 | 1.904 | -0.39 |
投資活動産生的現金 | 18.002 | 58.952 | -52.431 | -17.747 | -46.754 |
資本支出 | -0.133 | -0.18 | -0.052 | -0.055 | -0.212 |
其他投資現金流量項目,總計 | 18.135 | 59.132 | -52.379 | -17.692 | -46.542 |
融資活動産生的現金 | 0.707 | 6.808 | 118.876 | 77.366 | 75.928 |
股票的發行(報廢),淨額 | 0.756 | 6.808 | 118.91 | 77.925 | 75.678 |
債務的發行(退還),淨額 | -0.049 | 0 | -0.034 | -0.559 | 0.25 |
現金淨變化 | -25.145 | 2.883 | 15.627 | 26.342 | 17.479 |
外彙效應 | 0.184 | 0.055 | |||
Deferred Taxes | -0.284 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -12.254 | -51.66 | -46.126 | -38.205 | -21.641 |
Cash From Operating Activities | -3.569 | -44.038 | -38.203 | -31.506 | -16.091 |
Cash From Operating Activities | 0.017 | 0.204 | 0.162 | 0.122 | 0.038 |
Non-Cash Items | 7.238 | 17.437 | 16.03 | 14.565 | 9.375 |
Changes in Working Capital | 1.678 | -9.735 | -7.985 | -7.704 | -3.863 |
Cash From Investing Activities | 5.54 | 18.002 | -0.664 | 8.162 | 13.413 |
Capital Expenditures | -0.136 | -0.133 | -0.055 | -0.005 | -0.005 |
Other Investing Cash Flow Items, Total | 5.676 | 18.135 | -0.609 | 8.167 | 13.418 |
Cash From Financing Activities | 0.05 | 0.707 | 0.725 | 0.73 | 0.622 |
Issuance (Retirement) of Stock, Net | 0.056 | 0.756 | 0.756 | 0.742 | 0.622 |
Net Change in Cash | 2.135 | -25.145 | -37.915 | -22.796 | -2.16 |
Issuance (Retirement) of Debt, Net | -0.006 | -0.049 | -0.031 | -0.012 | |
Foreign Exchange Effects | 0.114 | 0.184 | 0.227 | -0.182 | -0.104 |
Deferred Taxes | -0.248 | -0.284 | -0.284 | -0.284 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
601 Gateway Boulevard, Suite 1250
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易